TARDBP and amyotrophic lateral sclerosis: Collectively, it appears that converging mechanisms—including posttranslational modification cascades, cross-talk with other ALS protein systems including TDP-43, and impaired autophagy—can exacerbate toxicity and thereby provide putative testable therapeutic targets [170].